Synonyms: APOC-III antisense inhibitor | ISIS 304801 | ISIS-APOCIIIRx | Waylivra®
volanesorsen is an approved drug (EMA (2019))
Compound class:
Synthetic organic
Comment: Volanesorsen is an antisense oligonucleotide (ASO) designed to reduce levels of apolipoprotein C-III (APOC3) in patients with elevated blood triglyceride levels [2]. Reducing triglycerides via APOC3 could be beneficial in patients with inherited hypertriglyceridemia (e.g. those with familial chylomicronemia syndrome, FCS) [1]. The role of APOC3 in hypertriglyceridemia and the effects APOC3 ASO use are reviewed in [3].
HELM annotation for this RNA (from PubChem) is RNA1{[MOE](A).[sp][MOE](G).[sp][MOE]([5meC]).[sp][MOE](T).[sp][MOE](T).[sp][dR]([5meC]).[sp][dR](T).[sp][dR](T).[sp][dR](G).[sp][dR](T).[sp][dR]([5meC]).[sp][dR]([5meC]).[sp][dR](A).[sp][dR](G).[sp][dR]([5meC]).[sp][MOE](T).[sp][MOE](T).[sp][MOE](T).[sp][MOE](A).[sp][MOE](T)}$$$$. |
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (EMA (2019)) |
International Nonproprietary Names | |
INN number | INN |
10166 | volanesorsen |
Synonyms |
APOC-III antisense inhibitor | ISIS 304801 | ISIS-APOCIIIRx | Waylivra® |
Database Links | |
CAS Registry No. | 915430-78-3 (source: WHO INN record) |
GtoPdb PubChem SID | 252166881 |
PubChem CID | 121494123 |
Search Google for chemical match using the InChIKey | IJUQCWMZCMFFJP-GQSLRNSLSA-N |
Search Google for chemicals with the same backbone | IJUQCWMZCMFFJP |
Search PubMed clinical trials | volanesorsen |
Search PubMed titles | volanesorsen |
Search PubMed titles/abstracts | volanesorsen |
UniChem Compound Search for chemical match using the InChIKey | IJUQCWMZCMFFJP-GQSLRNSLSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | IJUQCWMZCMFFJP-GQSLRNSLSA-N |